Below are the financial statements of United Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total revenues | 2,877.4a | 2,327.5a | 1,936.3a |
| Operating expenses | — | — | — |
| Cost of sales | -309.7a | -257.5a | -151.6a |
| Research and development | -481a | -408a | -322.9a |
| Selling, general, and administrative | -709.7a | -477.1a | -482.1a |
| Total operating expenses | -1,500.4a | -1,142.6a | -956.6a |
| Operating income | 1,377a | 1,184.9a | 979.7a |
| Interest income | 199.1a | 162.7a | 45.2a |
| Interest expense | -42.9a | -59.3a | -32.4a |
| Other income (expense), net | 5.8a | -14a | -40.2a |
| Impairment of investment in privately-held company | 0a | 0a | -1.7a |
| Total other income (expense), net | 162a | 89.4a | -29.1a |
| Income before income taxes | 1,539a | 1,274.3a | 950.6a |
| Income tax expense | -343.9a | -289.5a | -223.3a |
| Net income | 1,195.1a | 984.8a | 727.3a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore United Therapeutics’s data sources below and access millions more through our Disclosure Search.